Monitoring Intervals in Hemodialysis Centers

Dialysis Adequacy Monitoring

The American Journal of Kidney Diseases recommends that the delivered dose of hemodialysis must be measured at least monthly in all adult and pediatric hemodialysis patients using Kt/V or URR measurements 1, 2
Kt/V measurements should be performed monthly with predialysis and postdialysis BUN samples drawn at the same hemodialysis session and analyzed simultaneously to minimize interassay variability 1, 2
Target single pool Kt/V should be 1.4 per session for thrice-weekly treatments, with minimum delivered spKt/V of 1.2 3
Monthly biochemical evaluations align pragmatically with institutional reporting cycles and ensure timely detection of inadequate dialysis delivery 1, 2

The American Heart Association, as reported in Circulation, recommends baseline and annual ECGs for all hemodialysis patients, with additional monitoring based on clinical status 4
Baseline ECG should be performed at dialysis initiation as part of cardiovascular disease evaluation 4
Annual ECGs should be obtained for routine surveillance given the high prevalence of rhythm abnormalities 4
Atrial fibrillation occurs more frequently on hemodialysis days and increases during the procedure itself, with QTc prolongation identified as an independent predictor of mortality 4
The American Journal of Kidney Diseases recommends that all patients require echocardiography at dialysis initiation and at 3-yearly intervals thereafter 5
Initial echocardiogram should be performed once dry weight is achieved, ideally within 1-3 months of dialysis initiation 5
Re-evaluate with echocardiography when clinical status changes: symptoms of congestive heart failure, recurrent hypotension on dialysis, post-cardiac events, or consideration for kidney transplant 5
Patients with ejection fraction <40% require evaluation for coronary artery disease through stress imaging or coronary angiography 5

The American Heart Association, as reported in Circulation, recommends continuous electrocardiographic monitoring for hospitalized hemodialysis patients with new acute renal failure with severe electrolyte abnormalities, ICU admission requiring dialysis, or drug intoxication with proarrhythmic drugs requiring QT monitoring in addition to arrhythmia monitoring 4, 6
Development of tachycardia during dialysis, particularly with severe electrolyte abnormalities, QT-prolonging medications, or known structural heart disease, requires continuous monitoring 6, 4

The American Heart Association, as reported in Circulation, recommends that automatic external defibrillators should be available in all outpatient hemodialysis clinics given the 7 cardiac arrests per 100,000 dialysis sessions, with 62% presenting as ventricular fibrillation/ventricular tachycardia 7
Sudden cardiac death occurs most commonly during the 72-hour timeframe between dialysis treatments and within the first 12 hours after receiving treatment 4
Intradialytic blood pressure and heart rate monitoring should occur throughout each session, as pre-hemodialysis pulse rate ≥80 bpm carries significantly increased 1-year mortality risk 7

The American Journal of Kidney Diseases recommends that objective Kt/V measurements are essential, and symptoms are unreliable indicators, so do not rely on clinical signs and symptoms alone to assess dialysis adequacy 1, 2
Do not measure Kt/V less frequently than monthly as this compromises timely detection of inadequate dialysis and delays corrective action 1, 2
Do not draw predialysis and postdialysis BUN samples from different sessions as this provides meaningless information about delivered dialysis dose 1, 2
The American Journal of Kidney Diseases recommends that do not defer echocardiography beyond 3 months post-dialysis initiation as the 75% prevalence of cardiac dysfunction requires early identification 5
The American Heart Association, as reported in Circulation, recommends that do not assume stable outpatients require continuous ECG monitoring during routine dialysis sessions, as evidence for benefit is lacking in this population 4, 6

The American Journal of Kidney Diseases recommends increasing monitoring frequency to every 15-30 minutes when ultrafiltration rates are high or aggressive fluid removal is occurring, and measuring pre-dialysis weight at the start of each session to calculate required ultrafiltration volume, as well as measuring post-dialysis weight at the end of each session to verify achievement of target fluid removal 8

The American Journal of Kidney Diseases suggests measuring pre-dialysis weight at the start of each session and post-dialysis weight at the end of each session to calculate and verify ultrafiltration volume 8